Khan and Iqbal: Hepatoprotective Activity of Fumaria farviflora Lam. Leaves ExtractIsoniazid and rifampicin are first line drugs used for the treatment of tuberculosis but their use is associated with potentially serious toxic manifestation in the liver leading to necrosis, cirrhosis and hepatitis causing poor patient compliance. The present study was conducted to evaluate hepatoprotective activity of Fumaria parviflora leaf extract in isoniazid and rifampicin-induced hepatotoxic rats. Acute toxicity was conducted with single oral doses of F. parviflora leaf extracts at 300, 2000 and 5000 mg/kg and rats were observed for changes in body weight, haematological parameters, behavioural changes and signs of toxicity. Hepatoprotective activity of F. parviflora leaf extract (100, 200 and 300 mg/kg, p.o.) was evaluated on isoniazid and rifampicin (50 mg/kg, i.p.) induced hepatotoxic rats using silymarin as a reference drug (100 mg/kg, p.o.). F. parviflora leaf extract was found to be safe up to 5 g/kg. From biochemical and histopathological parameters it was found that pretreatment of rats with F. parviflora leaf extract an hour prior to start isoniazid and rifampicin resulted in a significant decline in the serum levels of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase and total bilirubin as well as normal histology of liver biopsy specimens. It was concluded that F. parviflora leaf extract has significant hepatoprotective activity at the dose of 200 mg/kg comparable with that of silymarin. The plant extract appeared to have the potential to be used as a dietary supplement to antiTB therapy to protect against the hepatotoxicity of isoniazid and rifampicin.
OBJECTIVE: Evaluation of hepatoprotective potentials of Ocimum sanctum against Valproic-acid-induced-hepatotoxicity in Wistar-albino-rats. METHOD: 70% of ethanolic extract of Ocimum sanctum was prepared under reduced pressure of rotary evaporator. Wistar albino rats were used as the experimental model and rats were divided into four groups (six animals each). The normal group received normal saline and group 2, 3 and 4 was injected valproic acid (500mg/kg) for four consecutive days respectively. Group 1 and 2 received normal saline throughout the period of study about 21 days while group 3 and 4 received different doses of extract of OS i.e. 200mg/kg and 300mg/kg. Through retro-orbital blood samples were collected on alternative days such as 0,7,21. By using one-way ANOVA, data was analyzed. Hepatotoxicity induced by valproic acid at the dosage of (500mg/kg) resulted in significant elevation in weight of animals and serum hepatic enzymes level of ALAT, ASAT, ALP and increase in the serum bilirubin. RESULTS: OS at different doses (200mg/kg and 300mg/kg) considered statistically significant (p ≤ 0.05) against all parameters. OS cause a significant reduction in weight of animals and serum enzymes biomarkers i.e. (ALAT, ASAT and ALP) including bilirubin content. OS may prove its hepatoprotective activity by increase a significant level of protein albumin. CONCLUSION: antioxidant activity of OS and secondary metabolites such as flavonoids depicts hepatoprotective nature against valproic-acid-induced-hepatotoxicity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.